What is it about?
a review about the bile acid modified NorUDCA and its potential therapeutic roles in cholestatic diseases as well as in cholangiopathies and metabolism
Featured Image
Why is it important?
it gives a clear overview on a drug which is in final clinical trials and could be a game changer in hepatology
Read the Original
This page is a summary of: Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders, Digestive Diseases, May 2015, Karger Publishers,
DOI: 10.1159/000371904.
You can read the full text:
Contributors
The following have contributed to this page